Cost-effectiveness analysis of magnetic resonance-guided focused ultrasound ablation for palliation of refractory painful bone metastases.

Matthew D BucknorFrandics P ChanJessica Y MatuokaPatti K CurlJames G Kahn

Published in: International journal of technology assessment in health care (2020)

Our model demonstrates that MRgFUS is cost-effective compared with Medication Only for palliation of painful bone metastases for patients with medically refractory metastatic bone pain across a range of sensitivity analyses.

Keyphrases

magnetic resonance
chronic pain
squamous cell carcinoma
small cell lung cancer
pain management
healthcare
bone mineral density
neuropathic pain
contrast enhanced
radiofrequency ablation
emergency department
bone loss
spinal cord injury
catheter ablation